{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:28:29Z","timestamp":1792081709619,"version":"4.4.0"},"reference-count":214,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.pbb.2008.01.001","type":"journal-article","created":{"date-parts":[[2008,1,15]],"date-time":"2008-01-15T07:18:57Z","timestamp":1200381537000},"page":"74-89","source":"Crossref","is-referenced-by-count":169,"title":["Abuse and dependence liability of benzodiazepine-type drugs: GABAA receptor modulation and beyond"],"prefix":"10.1016","volume":"90","author":[{"given":"Stephanie C.","family":"Licata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James K.","family":"Rowlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2008.01.001_bib1","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/sj.npp.1300800","article-title":"Differential effects of two chronic diazepam treatment regimes on withdrawal anxiety and AMPA receptor characteristics","volume":"31","author":"Allison","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00008877-200209000-00015","article-title":"Diazepam withdrawal-induced anxiety and place aversion in the rat: differential effects of two chronic diazepam treatment regimes","volume":"13","author":"Allison","year":"2002","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib3","series-title":"Top 200 drugs of 1995","author":"American Druggist","year":"1996"},{"key":"10.1016\/j.pbb.2008.01.001_bib4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF00572441","article-title":"Pharmacological profile of the imidazopyridine zolpidem at benzodiazepine receptors and electrocorticogram in rats","volume":"330","author":"Arbilla","year":"1985","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0740-5472(91)90023-4","article-title":"Protracted withdrawal syndromes from benzodiazepines","volume":"8","author":"Ashton","year":"1991","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.pbb.2008.01.001_bib6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.105.089920","article-title":"TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxyl)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridzine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates","volume":"316","author":"Atack","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2008.01.001_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0376-8716(00)00123-X","article-title":"Zaleplon and triazolam: drug discrimination, plasma levels, and self-administration in baboons","volume":"24","author":"Ator","year":"2000","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pbb.2008.01.001_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1017\/S1092852900009883","article-title":"Contributions of GABAA receptor subtype selectivity to abuse liability and dependence potential of pharmacological treatments for anxiety and sleep disorders","volume":"10","author":"Ator","year":"2005","journal-title":"CNS Spectr"},{"key":"10.1016\/j.pbb.2008.01.001_bib9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0091-3057(87)90588-0","article-title":"Self-administration of barbiturates and benzodiazepines: a review","volume":"27","author":"Ator","year":"1987","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2008.01.001_bib10","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S0376-8716(03)00099-1","article-title":"Principles of drug abuse liability assessment in laboratory animals","volume":"70","author":"Ator","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pbb.2008.01.001_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0376-8716(00)00122-8","article-title":"Zaleplon and triazolam physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons","volume":"61","author":"Ator","year":"2000","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pbb.2008.01.001_bib12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.molmed.2006.10.005","article-title":"Drug addiction: the neurobiology of disrupted self-control","volume":"12","author":"Baler","year":"2006","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.pbb.2008.01.001_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1615\/CritRevNeurobiol.v12.i1-2.30","article-title":"Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens","volume":"12","author":"Bardo","year":"1998","journal-title":"Crit Rev Neurobiol"},{"issue":"Suppl 1","key":"10.1016\/j.pbb.2008.01.001_bib14","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S1389-9457(04)90002-0","article-title":"The benzodiazepine site of the GABAA receptor: an old target with new potential?","volume":"5","author":"Bateson","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/j.pbb.2008.01.001_bib15","first-page":"401","article-title":"Long-term potentiation and kindling: similar biochemical mechanisms?","volume":"44","author":"Baudry","year":"1986","journal-title":"Adv Neurol"},{"key":"10.1016\/j.pbb.2008.01.001_bib16","first-page":"1033","article-title":"In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the omega 1 (BZD1) subtype","volume":"245","author":"Benavides","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2008.01.001_bib17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/BF00431693","article-title":"The reinforcing properties of diazepam under several conditions in the rhesus monkey","volume":"86","author":"Bergman","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/026988119100500306","article-title":"Flumazenil-precipitated withdrawal symptoms in chronic users of therapeutic doses of diazepam","volume":"5","author":"Bernik","year":"1991","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/026988119801200205","article-title":"Stressful reactions and panic attacks induced by flumazenil in chronic benzodiazepine users","volume":"12","author":"Bernik","year":"1998","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib20","first-page":"161","article-title":"Effects of zolpidem on the architecture and cyclical structure of sleep in poor sleepers","volume":"21","author":"Besset","year":"1995","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.pbb.2008.01.001_bib21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/08977190410001723308","article-title":"Brain-derived neurotrophic factor","volume":"22","author":"Binder","year":"2004","journal-title":"Growth Factors"},{"key":"10.1016\/j.pbb.2008.01.001_bib22","first-page":"797","article-title":"Effect of zolpidem on sleep in healthy subjects: a placebo-controlled trial with polysomnographic recordings","volume":"15","author":"Blois","year":"1993","journal-title":"Clin Ther"},{"key":"10.1016\/j.pbb.2008.01.001_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00213-004-1986-4","article-title":"Self-administration of methohexital, midazolam and ethanol: effects on the pituitary\u2013adrenal axis in rhesus monkeys","volume":"178","author":"Broadbear","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib24","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1046\/j.0953-816x.2001.01506.x","article-title":"BDNF reduces miniature inhibitory postsynaptic currents by rapid downregulation of GABA(A) receptor surface expression","volume":"13","author":"Br\u00fcnig","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pbb.2008.01.001_bib25","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1471-4159.2005.03074.x","article-title":"In vivo up-regulation of brain-derived neurotrophic factor in specific brain areas by chronic exposure to delta-tetrahydrocannabinol","volume":"93","author":"Butovsky","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2008.01.001_bib26","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/00003246-199804000-00015","article-title":"Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients","volume":"26","author":"Cammarano","year":"1998","journal-title":"Crit Care Med"},{"key":"10.1016\/j.pbb.2008.01.001_bib27","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/sj.bjp.0706796","article-title":"Mechanism of action of benzodiazepines on GABAA receptors","volume":"148","author":"Campo-Soria","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/1534582302238338","article-title":"The nucleus accumbens and reward: neurophysiological investigations in behaving animals","volume":"1","author":"Carelli","year":"2002","journal-title":"Behav Cogn Neurosci Rev"},{"key":"10.1016\/j.pbb.2008.01.001_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0014-2999(01)00851-2","article-title":"Sedative and anxiolytic effects of zopiclone's enantiomers and metabolite","volume":"415","author":"Carlson","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0964-3397(97)80012-2","article-title":"Adverse reactions to the withdrawal of opioids and benzodiazepines in paediatric intensive care","volume":"13","author":"Carnevale","year":"1997","journal-title":"Intensive Crit Care Nurs"},{"key":"10.1016\/j.pbb.2008.01.001_bib31","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1046\/j.1471-4159.2002.01032.x","article-title":"Calcium\/calmodulin-dependent kinase II phosphorylation of the GABAA receptor alpha1 subunit modulates benzodiazepine binding","volume":"82","author":"Churn","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2008.01.001_bib32","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1176\/ajp.145.12.1501","article-title":"Critical review of liability for benzodiazepine abuse among alcoholics","volume":"145","author":"Ciraulo","year":"1988","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2008.01.001_bib33","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1523\/JNEUROSCI.22-13-05572.2002","article-title":"Enhanced learning and memory altered GABAergic synaptic transmission in mice lacking the \u03b15 subunit of the GABAA receptor","volume":"22","author":"Collinson","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2008.01.001_bib34","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/BF00175035","article-title":"The effect of cyclopyrrolones on GABAA receptor function is different from that of benzodiazepines","volume":"350","author":"Concas","year":"1994","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib35","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000103570","article-title":"Brain-derived neurotrophic factor and its intracellular signaling pathways in cocaine addiction","volume":"55","author":"Corominas","year":"2007","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pbb.2008.01.001_bib36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/sj.npp.1380249","article-title":"Benzodiazepine sensitivity in panic disorder: effects of chronic alprazolam treatment","volume":"12","author":"Cowley","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib37","series-title":"The DAWN Report, Office of Applied Studies, US Substance Abuse and Mental Health Services Administration","article-title":"Demographic characteristics of benzodiazepine-involved ED visits","author":"Crane","year":"2004"},{"key":"10.1016\/j.pbb.2008.01.001_bib38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0028-3908(82)90216-7","article-title":"Chronic clonazepam administration induces benzodiazepine receptor subsensitivity","volume":"21","author":"Crawley","year":"1982","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib39","doi-asserted-by":"crossref","first-page":"8980","DOI":"10.1073\/pnas.142288699","article-title":"Trace fear conditioning involves hippocampal \u03b15 GABAA receptors","volume":"99","author":"Crestani","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2008.01.001_bib40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0376-8716(93)90047-T","article-title":"Drug use, HIV risk-taking and psychosocial correlates of benzodiazepine use among methadone maintenance clients","volume":"34","author":"Darke","year":"1994","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pbb.2008.01.001_bib41","doi-asserted-by":"crossref","first-page":"645","DOI":"10.5694\/j.1326-5377.1995.tb126051.x","article-title":"Benzodiazepine use among injecting heroin users","volume":"162","author":"Darke","year":"1995","journal-title":"Med J Aust"},{"key":"10.1016\/j.pbb.2008.01.001_bib213","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1017\/S1092852900009871","article-title":"Development of subtype selective GABAA modulators","volume":"10","author":"Dawson","year":"2005","journal-title":"CNS Spectr"},{"key":"10.1016\/j.pbb.2008.01.001_bib42","first-page":"649","article-title":"Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects","volume":"237","author":"Depoortere","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2008.01.001_bib43","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF02245577","article-title":"Preference for ethanol and diazepam in light and moderate social drinkers: a within-subjects study","volume":"115","author":"de Wit","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib44","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic dopamine system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2008.01.001_bib45","first-page":"65","article-title":"Drugs of abuse: biochemical surrogates of specific aspects of natural reward?","volume":"59","author":"Di Chiara","year":"1993","journal-title":"Biochem Soc Symp"},{"issue":"Suppl A","key":"10.1016\/j.pbb.2008.01.001_bib46","first-page":"A44","article-title":"Acute benzodiazepine withdrawal delirium after a short course of flunitrazepam in an intensive care patient","volume":"151","author":"Diehl","year":"2000","journal-title":"Ann Med Interne (Paris)"},{"issue":"4 Suppl 1","key":"10.1016\/j.pbb.2008.01.001_bib47","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1177\/026988119901304S03","article-title":"New insights into the mechanism of action of hypnotics","volume":"13","author":"Doble","year":"1999","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib48","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2165\/00003495-200060020-00014","article-title":"Zaleplon: a review of its use in the treatment of insomnia","volume":"60","author":"Dooley","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.pbb.2008.01.001_bib49","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2165\/00003495-198428060-00002","article-title":"Midazolam: a review of its pharmacological properties and therapeutic use","volume":"28","author":"Dundee","year":"1984","journal-title":"Drugs"},{"key":"10.1016\/j.pbb.2008.01.001_bib214","first-page":"458","article-title":"Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study","volume":"47","author":"Dunner","year":"1986","journal-title":"J Clin Psychiatry"},{"issue":"suppl 1","key":"10.1016\/j.pbb.2008.01.001_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00952998809020204","article-title":"Abuse of benzodiazepines: the problems and the solutions","volume":"14","author":"Du Pont","year":"1988","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.pbb.2008.01.001_bib51","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0091-3057(00)00176-3","article-title":"Precipitated and spontaneous withdrawal following administration of lorazepam but not zolpidem","volume":"66","author":"Elliott","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"issue":"Suppl 9","key":"10.1016\/j.pbb.2008.01.001_bib52","first-page":"18","article-title":"Therapeutic options in the treatment of insomnia","volume":"66","author":"Erman","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pbb.2008.01.001_bib53","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/BF00428151","article-title":"Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems","volume":"78","author":"Ettenberg","year":"1982","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib54","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF02246172","article-title":"Preference for diazepam, but not buspirone, in moderate drinkers","volume":"123","author":"Evans","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib55","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/BF02801973","article-title":"Benzodiazepine-induced decreases in extracellular concentrations of dopamine in the nucleus accumbens after acute and repeated administration","volume":"106","author":"Finlay","year":"1992","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib56","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00315021","article-title":"Excessive motor impairment two hours after triazolam in the elderly","volume":"38","author":"Fisch","year":"1990","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib57","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0169-328X(01)00164-4","article-title":"Increase in expression of the GABAA receptor \u03b14 subunit gene induced by withdrawal of, but not long-term treatment with, benzodiazepine full or partial agonists","volume":"92","author":"Follesa","year":"2001","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.pbb.2008.01.001_bib58","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1600-0447.1986.tb06268.x","article-title":"Bromazepam and lorazepam in generalized anxiety: a placebo-controlled study with measurement of drug plasma concentrations","volume":"74","author":"Fontaine","year":"1986","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pbb.2008.01.001_bib59","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0376-8716(93)90092-5","article-title":"The dual use of opioids and temazepam by drug injectors in Glasgow (Scotland)","volume":"32","author":"Forsyth","year":"1993","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pbb.2008.01.001_bib60","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.iccn.2004.07.008","article-title":"Opioid and benzodiazepine withdrawal symptoms in paediatric intensive care patients","volume":"20","author":"Franck","year":"2004","journal-title":"Intensive Crit Care Nurs"},{"key":"10.1016\/j.pbb.2008.01.001_bib61","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/308074a0","article-title":"Chronic benzodiazepine treatment decreases postsynaptic GABA sensitivity","volume":"308","author":"Gallager","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2008.01.001_bib62","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0376-8716(98)00175-6","article-title":"Characteristics of benzodiazepine abuse in methadone maintenance treatment patients: a 1\u00a0year prospective study in an Israeli clinic","volume":"55","author":"Gelkopf","year":"1999","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pbb.2008.01.001_bib63","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0304-3940(99)00371-7","article-title":"A role for AMPA\/kainite receptors in conditioned place preferences induced by diazepam in the rat","volume":"268","author":"Gray","year":"1999","journal-title":"Neurosci Lett"},{"issue":"Suppl 1","key":"10.1016\/j.pbb.2008.01.001_bib64","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1111\/j.1365-2125.1981.tb01833.x","article-title":"Benzodiazepines: a summary of pharmacokinetic properties","volume":"11","author":"Greenblatt","year":"1981","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib65","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0009-9236(98)90139-4","article-title":"Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo","volume":"64","author":"Greenblatt","year":"1998","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 9","key":"10.1016\/j.pbb.2008.01.001_bib66","first-page":"31","article-title":"Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds","volume":"66","author":"Griffiths","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pbb.2008.01.001_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050422","article-title":"Benzodiazepine self-administration in humans and laboratory animals\u2014implications for problems of long-term use and abuse","volume":"134","author":"Griffiths","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib68","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00004714-199008000-00002","article-title":"Relative abuse liability of different benzodiazepines in drug abusers","volume":"10","author":"Griffiths","year":"1990","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib69","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF02244196","article-title":"Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboons","volume":"103","author":"Griffiths","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib70","first-page":"1199","article-title":"Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal","volume":"260","author":"Griffiths","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2008.01.001_bib71","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0376-8716(03)00098-X","article-title":"Principles of initial experimental drug abuse liability assessment in humans","volume":"70","author":"Griffiths","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pbb.2008.01.001_bib72","first-page":"970","article-title":"Cloning of cDNA sequences encoding human \u03b12 and \u03b13 \u03b3-aminobutyric acidA receptor subunits and characterization of the benzodiazepine pharmacology of recombinant \u03b11-, \u03b12-, \u03b13-, and \u03b15-containing human \u03b3-aminobutyric acidA receptors","volume":"43","author":"Hadingham","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib73","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1046\/j.1360-0443.2003.00491.x","article-title":"Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data","volume":"98","author":"Hajak","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.pbb.2008.01.001_bib74","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/026988119601000201","article-title":"Flumazenil-precipitated panic and dysphoria in patients dependent on benzodiazepines: a possible aid to abstinence","volume":"10","author":"Harrison-Read","year":"1996","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib75","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1037\/1064-1297.13.4.348","article-title":"Reinforcing effects of diazepam under anxiogenic conditions in individuals with social anxiety","volume":"13","author":"Helmus","year":"2005","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib76","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF02876917","article-title":"Effect of continuous diazepam administration on GABAA subunit mRNA in rat brain","volume":"2","author":"Heninger","year":"1990","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.pbb.2008.01.001_bib77","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-2999(89)90535-9","article-title":"Relationship of agonist efficacy to changes in GABA sensitivity and anticonvulsant tolerance following chronic benzodiazepine ligand exposure","volume":"170","author":"Hernandez","year":"1989","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib78","first-page":"158","article-title":"Clonazepam treatment of obsessions and compulsions","volume":"51","author":"Hewlett","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pbb.2008.01.001_bib79","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/00004714-199212000-00008","article-title":"Clomipramine, clonazepam, and clonidine treatment of obsessive\u2013compulsive disorder","volume":"12","author":"Hewlett","year":"1992","journal-title":"J Clin Psychopharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.pbb.2008.01.001_bib80","first-page":"1","article-title":"Clinical uses of benzodiazepines","volume":"13","author":"Hollister","year":"1993","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib81","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0028-3908(96)00064-0","article-title":"Chronic treatment with diazepam or abecarnil differently affects the expression of GABAA receptor subunit mRNAs in the rat cortex","volume":"35","author":"Holt","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib82","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0169-328X(97)00129-0","article-title":"Chronic diazepam exposure decreases transcription of the rat GABAA receptor \u03b32-subunit gene","volume":"48","author":"Holt","year":"1997","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.pbb.2008.01.001_bib83","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1046\/j.1471-4159.1999.0722219.x","article-title":"Decreased GABA enhancement of benzodiazepine binding after a single dose of diazepam","volume":"72","author":"Holt","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2008.01.001_bib84","first-page":"618","article-title":"Chronic benzodiazepine agonist treatment produces functional uncoupling of the \u03b3-aminobutyric acid-benzodiazepine receptor ionophore complex in cortical neurons","volume":"45","author":"Hu","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib85","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1046\/j.1471-4159.2003.02216.x","article-title":"Diazepam-induced adaptive plasticity revealed by \u03b11 GABAA receptor-specific expression profiling","volume":"88","author":"Huopaniemi","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2008.01.001_bib86","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0376-8716(93)90090-D","article-title":"Benzodiazepine and sedative use\/abuse by methadone maintenance clients","volume":"32","author":"Iguchi","year":"1993","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pbb.2008.01.001_bib87","first-page":"822","article-title":"Modifications of \u03b3-aminobutyric acid receptor subunit expression in rat neocortex during tolerance to diazepam","volume":"49","author":"Impagnatiello","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib88","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0028-3908(91)90075-M","article-title":"Release of dopamine is reduced by diazepam more in the nucleus accumbens than in the caudate nucleus of conscious rats","volume":"30","author":"Invernizzi","year":"1991","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib89","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1073\/pnas.051628698","article-title":"Glutamic acid decarboxylase and glutamate receptor changes during tolerance and dependence to benzodiazepines","volume":"98","author":"Izzo","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2008.01.001_bib90","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1360-0443.2003.00631.x","article-title":"A postmarketing study of relative abuse liability of hypnotic sedative drugs","volume":"99","author":"Jaffe","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.pbb.2008.01.001_bib91","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1087-0792(03)00025-X","article-title":"Treatment of insomnia associated with clinical depression","volume":"8","author":"Jindal","year":"2004","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.pbb.2008.01.001_bib92","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00004714-198304000-00038","article-title":"Sleep laboratory studies of hypnotic drugs: efficacy and withdrawal effects","volume":"3","author":"Kales","year":"1983","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib93","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1176\/appi.ajp.162.8.1403","article-title":"The neural basis of addiction: a pathology of motivation and choice","volume":"162","author":"Kalivas","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2008.01.001_bib94","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.amjmed.2005.10.051","article-title":"Insomnia in the elderly: cause, approach, and treatment","volume":"119","author":"Kamel","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.pbb.2008.01.001_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jjp.70.1","article-title":"Regulation of GABAA receptor structure and function by chronic drug treatments in vivo and with stably transfected cells","volume":"70","author":"Klein","year":"1996","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib96","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/07853899708999348","article-title":"GABAA-receptor subtypes: clinical efficacy and selectivity of benzodiazepine-site ligands","volume":"29","author":"Korpi","year":"1997","journal-title":"Ann Med"},{"key":"10.1016\/j.pbb.2008.01.001_bib97","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/sleep\/26.7.793","article-title":"Sustained efficacy of eszopiclone over 6\u00a0months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia","volume":"26","author":"Krystal","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.pbb.2008.01.001_bib98","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0006-8993(98)01341-9","article-title":"Benzodiazepine withdrawal facilitates the subsequent onset of escape failures and anhedonia: influence of different antidepressant drugs","volume":"819","author":"Lacerra","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2008.01.001_bib99","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1360-0443.1994.tb03746.x","article-title":"Stimulant withdrawal","volume":"89","author":"Lago","year":"1994","journal-title":"Addiction"},{"key":"10.1016\/j.pbb.2008.01.001_bib100","first-page":"379","article-title":"Contribution of zolpidem in the management of sleep disorders","volume":"18","author":"Lavoisy","year":"1992","journal-title":"Encephale"},{"key":"10.1016\/j.pbb.2008.01.001_bib101","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1037\/1064-1297.8.3.294","article-title":"Using behavior to elucidate receptor mechanisms: a review of the discriminative stimulus effects of benzodiazepines","volume":"8","author":"Lelas","year":"2000","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib102","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1525-1381.1999.09218.x","article-title":"Drugs of abuse and the brain","volume":"111","author":"Leshner","year":"1999","journal-title":"Proc Assoc Am Physicians"},{"key":"10.1016\/j.pbb.2008.01.001_bib103","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/0269881103017001723","article-title":"Zolpidem dependence case series: possible neurobiological mechanisms and clinical management","volume":"17","author":"Liappas","year":"2003","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib104","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.0953-816X.2003.03110.x","article-title":"Suppressing calcium\/calmodulin-dependent kinase II activity in the ventral tegmental area enhances the acute behavioural response to cocaine but attenuates the initiation of cocaine-induced behavioural sensitization in rats","volume":"19","author":"Licata","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pbb.2008.01.001_bib105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.drugalcdep.2007.05.019","article-title":"Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients","volume":"91","author":"Lintzeris","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pbb.2008.01.001_bib106","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0028-3908(88)90147-5","article-title":"Chronic benzodiazepine treatment increases the effects of the inverse agonist FG 7142","volume":"27","author":"Little","year":"1988","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib107","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00007611-199307000-00006","article-title":"Carisoprodol (Soma): a new and cautious perspective on an old agent","volume":"86","author":"Littrell","year":"1993","journal-title":"South Med J"},{"key":"10.1016\/j.pbb.2008.01.001_bib108","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-0327(99)00195-0","article-title":"Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression","volume":"61","author":"Londborg","year":"2000","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pbb.2008.01.001_bib109","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S0028-3908(96)00071-8","article-title":"Reversible modification of GABAA receptor subunit mRNA expression during tolerance to diazepam-induced cognition dysfunction","volume":"35","author":"Longone","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.290.5489.131","article-title":"Molecular and neuronal substrate for the selective attenuation of anxiety","volume":"290","author":"L\u00f6w","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.pbb.2008.01.001_bib111","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0014-2999(84)90218-8","article-title":"Precipitated withdrawal in baboons: effects of dose and duration of diazepam exposure","volume":"100","author":"Lukas","year":"1984","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib112","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF02245888","article-title":"Anxiogenic drugs beta-CCE and FG 7142 increase extracellular dopamine levels in nucleus accumbens","volume":"109","author":"McCullough","year":"1992","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib113","first-page":"139","article-title":"Which GABAA-receptor subtypes really occur in the brain?","volume":"19","author":"McKernan","year":"1996","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pbb.2008.01.001_bib114","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/10799899509045215","article-title":"The pharmacology of the benzodiazepine site of the GABA-A receptor is dependent upon the type of \u03b3-subunit present","volume":"15","author":"McKernan","year":"1995","journal-title":"J Recept Signal Transduct Res"},{"key":"10.1016\/j.pbb.2008.01.001_bib115","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/75761","article-title":"Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor alpha1 subtype","volume":"3","author":"McKernan","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pbb.2008.01.001_bib116","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0022-3565(24)29497-0","article-title":"Potency of positive \u03b3-aminobutyric acidA modulators to substitute for a midazolam discriminative stimulus in untreated monkeys does not predict potency to attenuate a flumazenil discriminative stimulus in diazepam-treated monkeys","volume":"298","author":"McMahon","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2008.01.001_bib117","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1176\/ajp.148.5.636","article-title":"Risk factors for needle sharing among methadone-treated patients","volume":"148","author":"Metzger","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2008.01.001_bib118","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/j.1552-4604.1991.tb03725.x","article-title":"Chronic benzodiazepine administration: from the patient to the gene","volume":"31","author":"Miller","year":"1991","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib119","first-page":"796","article-title":"Chronic clonazepam administration decreases \u03b3-aminobutryic acidA receptor function in cultured cortical neurons","volume":"36","author":"Miller","year":"1989","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib120","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00213-004-2009-1","article-title":"Flumazenil-precipitated withdrawal in healthy volunteers following repeated diazepam exposure","volume":"178","author":"Mintzer","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib121","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s002130051161","article-title":"A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users","volume":"147","author":"Mintzer","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib122","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1124\/jpet.105.094474","article-title":"Do subtype-selective GABAA receptor modulators have a reduced propensity to induce physical dependence in mice?","volume":"316","author":"Mirza","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 1","key":"10.1016\/j.pbb.2008.01.001_bib123","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1111\/j.1528-1157.1996.tb06025.x","article-title":"Status epilepticus and acute repetitive seizures in children, adolescents, and young adults: etiology, outcome, and treatment","volume":"37","author":"Mitchell","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.pbb.2008.01.001_bib124","doi-asserted-by":"crossref","first-page":"44097","DOI":"10.1074\/jbc.M305872200","article-title":"A rapid increase in the total number of cell surface functional GABAA receptors induced by brain-derived neurotrophic factor in rat visual cortex","volume":"278","author":"Mizoguchi","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pbb.2008.01.001_bib125","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00441-006-0284-3","article-title":"GABAA receptor diversity and pharmacology","volume":"326","author":"M\u00f6hler","year":"2006","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.pbb.2008.01.001_bib126","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1300\/J251v09n01_05","article-title":"Abuse liability of barbiturates and other sedative-hypnotics","volume":"9","author":"Morgan","year":"1990","journal-title":"Adv Alcohol Subst Abuse"},{"key":"10.1016\/j.pbb.2008.01.001_bib127","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.clinthera.2006.07.008","article-title":"Patient characteristics and patterns of drug use for sleep complaints in the United States: analysis of National Ambulatory Medical Survey Data, 1997\u20132002","volume":"28","author":"Morlock","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.pbb.2008.01.001_bib128","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s002130050262","article-title":"Enhancement by flumazenil of dopamine release in the nucleus accumbens of rats repeatedly exposed to diazepam or imidazenil","volume":"131","author":"Motzo","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib129","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0014-2999(94)90301-8","article-title":"Opposite effects of midazolam and beta-carboline-3-carboxylate ethyl ester on the release of dopamine from rat nucleus accumbens measured by in vivo microdialysis","volume":"261","author":"Murai","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib130","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.clinthera.2006.04.014","article-title":"Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia","volume":"28","author":"Najib","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.pbb.2008.01.001_bib131","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neuroscience.2004.03.006","article-title":"Role of the calcium\/calmodulin-dependent protein kinase ii (CaMKII) in the morphine-induced pharmacological effects in the mouse","volume":"126","author":"Narita","year":"2004","journal-title":"Neuroscience"},{"issue":"8 Suppl 8","key":"10.1016\/j.pbb.2008.01.001_bib132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1092852900026687","article-title":"New approaches in managing chronic insomnia","volume":"11","author":"Neubauer","year":"2006","journal-title":"CNS Spectr"},{"key":"10.1016\/j.pbb.2008.01.001_bib133","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1017\/S1092852900009901","article-title":"Overview of diagnosis and drug treatments of anxiety disorders","volume":"10","author":"Nutt","year":"2005","journal-title":"CNS Spectr"},{"key":"10.1016\/j.pbb.2008.01.001_bib134","first-page":"28","article-title":"Benzodiazepine use, abuse, and dependence","volume":"66","author":"O'Brien","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pbb.2008.01.001_bib135","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1360-0443.1987.tb01508.x","article-title":"The use of benzodiazepines among drug addicts","volume":"82","author":"Perera","year":"1987","journal-title":"Br J Addict"},{"key":"10.1016\/j.pbb.2008.01.001_bib136","first-page":"298","article-title":"Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem","volume":"263","author":"Perrault","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2008.01.001_bib137","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/j.1360-0443.1994.tb03743.x","article-title":"The benzodiazepine withdrawal syndrome","volume":"89","author":"Petursson","year":"1994","journal-title":"Addiction"},{"key":"10.1016\/j.pbb.2008.01.001_bib138","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0306-4522(00)00442-5","article-title":"GABAA receptors: immunocytochemical distribution of 13 subunits in the adult rat brain","volume":"101","author":"Pirker","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2008.01.001_bib139","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00213-002-1189-9","article-title":"Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA\/\u03b11-preferring antagonist \u03b2-CCT in squirrel monkeys","volume":"164","author":"Platt","year":"2002","journal-title":"Psychopharmacology"},{"issue":"Suppl 4","key":"10.1016\/j.pbb.2008.01.001_bib140","first-page":"S122","article-title":"Innovative uses of benzodiazepines in psychiatry","volume":"38","author":"Pollack","year":"1993","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.pbb.2008.01.001_bib141","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0091-3057(97)00539-X","article-title":"Benzodiazepine dependence: from neural circuits to gene expression","volume":"59","author":"Pratt","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2008.01.001_bib142","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/clpt.1984.215","article-title":"Diazepam and methadone interactions in methadone maintenance","volume":"36","author":"Preston","year":"1984","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pbb.2008.01.001_bib143","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1111\/j.1471-4159.1990.tb01237.x","article-title":"Gamma-aminobutyric acidA receptor alpha 5-subunit creates novel type II benzodiazepine receptor pharmacology","volume":"54","author":"Pritchett","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2008.01.001_bib144","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1073\/pnas.88.4.1421","article-title":"Gamma-aminobutyric acid type A receptor point mutation increases the affinity of compounds for the benzodiazepine site","volume":"88","author":"Pritchett","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2008.01.001_bib145","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1126\/science.2551039","article-title":"Type I and type II GABAA-benzodiazepine receptors produced in transfected cells","volume":"245","author":"Pritchett","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.pbb.2008.01.001_bib146","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/01.yic.0000166404.41850.b4","article-title":"Dependence on zolpidem: two case reports of detoxification with flumazenil infusion","volume":"20","author":"Quaglio","year":"2005","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib147","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2125.1994.tb04301.x","article-title":"Effects of zolpidem on sleep architecture, night time ventilation, daytime vigilance and performance in heavy snorers","volume":"37","author":"Quera-Salva","year":"1994","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib148","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0169-328X(96)00166-0","article-title":"Chronic triazolam and its withdrawal alters GABAA receptor subunit mRNA levels: an in situ hybridization study","volume":"43","author":"Ramsey-Williams","year":"1996","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.pbb.2008.01.001_bib149","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0014-2999(96)00527-4","article-title":"Propofol and flurazepam act synergistically to potentiate GABAA receptor activation in human recombinant receptors","volume":"314","author":"Reynolds","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib150","first-page":"710","article-title":"\u03b3-Aminobutyric acidA receptor regulation in culture: altered allosteric interactions following prolonged exposure to benzodiazepines, barbiturates, and methylxanthines","volume":"37","author":"Roca","year":"1990","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib151","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.sleep.2005.06.004","article-title":"An evaluation of the efficacy and safety of eszopiclone over 12\u00a0months in patients with chronic primary insomnia","volume":"6","author":"Roth","year":"2005","journal-title":"Sleep Med"},{"key":"10.1016\/j.pbb.2008.01.001_bib152","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1037\/1064-1297.15.4.328","article-title":"Comparison of zolpidem and midazolam self-administration under progressive-ratio schedules: consumer demand and labor supply analyses","volume":"15","author":"Rowlett","year":"2007","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib153","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1037\/1064-1297.10.4.367","article-title":"Self-administration of cocaine, alfentanil, and nalbuphine under progressive-ratio schedules: consumer demand and labor supply analysis of relative reinforcing effectiveness","volume":"10","author":"Rowlett","year":"2002","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib154","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1073\/pnas.0405621102","article-title":"Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates","volume":"102","author":"Rowlett","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2008.01.001_bib155","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/44579","article-title":"Benzodiazepine actions mediated by specific gamma-aminobutyric acid (A) receptor subtypes","volume":"401","author":"Rudolph","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2008.01.001_bib156","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0165-6147(00)01646-1","article-title":"GABAA receptor subtypes: dissecting their pharmacological functions","volume":"22","author":"Rudolph","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pbb.2008.01.001_bib157","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00213-006-0668-9","article-title":"Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits","volume":"191","author":"Salamone","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib158","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.me.36.020185.001245","article-title":"Geriatric psychopharmacology","volume":"36","author":"Salzman","year":"1985","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.pbb.2008.01.001_bib159","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF00174367","article-title":"The discriminative stimulus properties of zolpidem, a novel imdiazopyridine hypnotic","volume":"89","author":"Sanger","year":"1986","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib160","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/0028-3908(87)90172-9","article-title":"Investigation of the development of tolerance to the actions of zolpidem and midazolam","volume":"26","author":"Sanger","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib161","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0031-9384(87)90359-3","article-title":"The behavioral profile of zolpidem, a novel hypnotic drug of imidazopyridine structure","volume":"41","author":"Sanger","year":"1987","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pbb.2008.01.001_bib162","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0014-2999(96)00510-9","article-title":"Comparison of the pharmacological profiles of the hypnotics drugs, zaleplon and zolpidem","volume":"313","author":"Sanger","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib163","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0014-2999(02)02191-X","article-title":"Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes","volume":"451","author":"Sanna","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130100756","article-title":"Psychotogenic properties of benzodiazepine receptor inverse agonists","volume":"156","author":"Sarter","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib165","first-page":"261","article-title":"Barbiturates and the GABAA receptor complex","volume":"34","author":"Saunders","year":"1990","journal-title":"Prog Drug Res"},{"key":"10.1016\/j.pbb.2008.01.001_bib166","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/jat\/25.2.130","article-title":"Analytical methodology for the detection of benzodiazepine consumption in opioid-dependent subjects","volume":"25","author":"Segura","year":"2001","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.pbb.2008.01.001_bib167","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0006-8993(83)90404-3","article-title":"Depression of benzodiazepine binding and diazepam potentiation of GABA-mediated inhibition after chronic exposure of spinal cord cultures to diazepam","volume":"268","author":"Sher","year":"1983","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2008.01.001_bib168","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0006-8993(81)90929-X","article-title":"The insensitivity of developing benzodiazepine receptors to chronic treatment with diazepam","volume":"210","author":"Shibla","year":"1981","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2008.01.001_bib169","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pharmthera.2007.06.011","article-title":"Dynorphin and the pathophysiology of drug addiction","volume":"116","author":"Shippenberg","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pbb.2008.01.001_bib170","first-page":"1152","article-title":"Effect of the chronic dose of diazepam on the intensity and characteristic of the precipitated abstinence syndrome in the dog","volume":"265","author":"Sloan","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2008.01.001_bib171","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1124\/mol.59.5.1108","article-title":"Effect of a subunit on allosteric modulation of ion channel function in stably expressed human recombinant \u03b3-aminobutyric acidA receptors determined using 36Cl ion flux","volume":"59","author":"Smith","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib172","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1074\/jbc.R000013200","article-title":"Cellular signaling through multifunctional Ca2+\/calmodulin-dependent protein kinase II","volume":"276","author":"Soderling","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pbb.2008.01.001_bib173","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1124\/jpet.107.121798","article-title":"Benzodiazepine withdrawal-induced glutamatergic plasticity involves up-regulation of GluR1-containing alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in Hippocampal CA1 neurons","volume":"322","author":"Song","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2008.01.001_bib174","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pbb.2007.04.021","article-title":"The blockade of AMPA-kainate and NMDA receptors in the dorsal periaqueductal gray reduces the effects of diazepam withdrawal in rats","volume":"87","author":"Souza-Pinto","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2008.01.001_bib175","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1055\/s-2000-11224","article-title":"Epidemiological evidence for a low abuse potential of zolpidem","volume":"33","author":"Soyka","year":"2000","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pbb.2008.01.001_bib176","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/jhmas\/52.3.338","article-title":"From \u201chappiness pills\u201d to \u201cnational nightmare\u201d: changing cultural assessment of minor tranquilizers in America, 1955\u20131980","volume":"52","author":"Speaker","year":"1997","journal-title":"J Hist Med Allied Sci"},{"key":"10.1016\/j.pbb.2008.01.001_bib177","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00008877-199508000-00004","article-title":"A glutamatergic hypothesis of drug dependence","volume":"6","author":"Stephens","year":"1995","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib178","doi-asserted-by":"crossref","first-page":"21160","DOI":"10.1016\/S0021-9258(17)45340-3","article-title":"The \u03b32 subunit is an integral component of the \u03b3-aminobutyric acidA receptor but the \u03b11 polypeptide is the principle site of the agonist benzodiazepine photoaffinity labeling reaction","volume":"265","author":"Stephenson","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pbb.2008.01.001_bib179","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.1073\/pnas.90.14.6889","article-title":"Diazepam dependence prevented by glutamate antagonists","volume":"90","author":"Steppuhn","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2008.01.001_bib180","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0376-8716(81)90061-2","article-title":"Diazepam use among methadone maintenance patients: patterns and dosages","volume":"8","author":"Stitzer","year":"1981","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pbb.2008.01.001_bib181","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1081\/ADA-120020513","article-title":"Differential effects in humans after repeated administrations of zolpidem and triazolam","volume":"29","author":"Stoops","year":"2003","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.pbb.2008.01.001_bib182","series-title":"DAWN Series D-29, DHS Publication No. (SMA) 07-4256, Rockville MD","article-title":"Drug Abuse Warning Network, 2005: national estimates of drug-related emergency department visits","author":"Substance Abuse and Mental Health Services Administration, Office of Applied Studies","year":"2007"},{"key":"10.1016\/j.pbb.2008.01.001_bib183","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/274383a0","article-title":"GABAergic modulation of benzodiazepine binding site sensitivity","volume":"274","author":"Tallman","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2008.01.001_bib184","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0964-3397(99)80005-6","article-title":"Iatrogenic drug dependence\u2014a problem in intensive care? Case study and literature review","volume":"15","author":"Taylor","year":"1999","journal-title":"Intensive Crit Care Nurs"},{"key":"10.1016\/j.pbb.2008.01.001_bib185","first-page":"487","article-title":"Effect of hypnotic drugs on sleep architecture","volume":"46","author":"Terzano","year":"1994","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib186","unstructured":"The DASIS Report: Characteristics of primary tranquilizer admissions: 2002. Drug and Alcohol Services Information System, Office of Applied Studies, Substance Abuse and Mental Health Services Administration; 2005."},{"key":"10.1016\/j.pbb.2008.01.001_bib187","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/BF00212837","article-title":"Anxiogenic properties of beta-CCE and FG 7142: a review of promises and pitfalls","volume":"94","author":"Thi\u00e9bot","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib188","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/070674370505000702","article-title":"Listening to the past: history, psychiatry, and anxiety","volume":"50","author":"Tone","year":"2005","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.pbb.2008.01.001_bib189","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrn2132","article-title":"Epigenetic regulation in psychiatric disorders","volume":"8","author":"Tsankova","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pbb.2008.01.001_bib190","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(97)01501-X","article-title":"Upregulation of NMDA receptor subunit proteins in the cerebral cortex during diazepam withdrawal","volume":"341","author":"Tsuda","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib191","series-title":"Use and misuse of benzodiazepines","author":"U.S. Committee on Labor and Human Resources","year":"1979"},{"key":"10.1016\/j.pbb.2008.01.001_bib192","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1177\/106002809302700509","article-title":"Benzodiazepine withdrawal reaction in two children following discontinuation of sedation with midazolam","volume":"27","author":"van Engelen","year":"1993","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.pbb.2008.01.001_bib193","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1038\/sj.npp.1300531","article-title":"Transient plasticity of hippocampal CA1 neuron glutamate receptors contributes to benzodiazepine withdrawal-anxiety","volume":"29","author":"Van Sickle","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib194","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0893-133X(02)00310-X","article-title":"Effects of alprazolam on driving ability, memory functioning and psychomotor performance: a randomized, placebo-controlled study","volume":"27","author":"Verster","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0160-5402(91)90049-B","article-title":"A rapid screening method for the assessment of benzodiazepine receptor-related physical dependence in mice. Evaluation of benzodiazepine-related agonists and partial agonists","volume":"26","author":"VonVoigtlander","year":"1991","journal-title":"J Pharmacol Methods"},{"key":"10.1016\/j.pbb.2008.01.001_bib196","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.coph.2004.08.006","article-title":"GABAA receptor subtypes: any clues to the mechanism of benzodiazepine dependence?","volume":"5","author":"Wafford","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib197","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1037\/1064-1297.9.2.191","article-title":"Benzodiazepine modulation of opiate reward","volume":"9","author":"Walker","year":"2001","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib198","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0091-3057(03)00043-1","article-title":"The effects of alprazolam on conditioned place preferences produced by intravenous heroin","volume":"75","author":"Walker","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2008.01.001_bib199","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.pbb.2005.10.002","article-title":"Intra-ventral tegmental area heroin-induced place preferences in rats are potentiated by peripherally administered alprazolam","volume":"82","author":"Walker","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2008.01.001_bib200","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1152\/jn.1995.73.5.2099","article-title":"Alpha-subunit of calcium\/calmodulin-dependent protein kinase II enhances gamma-aminobutyric acid and inhibitory synaptic responses of rat neurons in vivo","volume":"73","author":"Wang","year":"1995","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.pbb.2008.01.001_bib201","first-page":"285","article-title":"Zolpidem self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons","volume":"9","author":"Weerts","year":"1998","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib202","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0022-3565(24)37370-7","article-title":"Zolpidem physical dependence assessed across increasing doses under a one-daily dosing regimen in baboons","volume":"285","author":"Weerts","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2008.01.001_bib203","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s002130050487","article-title":"Stable low-rate midazolam self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons","volume":"135","author":"Weerts","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib204","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00192735","article-title":"Effects of daytime administration of zolpidem versus triazolam on memory","volume":"48","author":"Wesensten","year":"1995","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib205","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0021-9258(18)45961-3","article-title":"A single histidine in GABAA receptors is essential for benzodiazepine agonist binding","volume":"267","author":"Wieland","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pbb.2008.01.001_bib206","first-page":"505","article-title":"Barbiturate-reinforced responding in rhesus monkeys: comparisons of drugs with different durations of action","volume":"195","author":"Winger","year":"1975","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2008.01.001_bib207","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF02245824","article-title":"Current benzodiazepine issues","volume":"118","author":"Woods","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2008.01.001_bib208","first-page":"151","article-title":"Benzodiazepines: use, abuse, and consequences","volume":"44","author":"Woods","year":"1992","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pbb.2008.01.001_bib209","first-page":"675","article-title":"Regional changes in [3H]zolpidem binding to brain benzodiazepine receptors in flurazepam tolerant rat: comparison with changes in [3H]flunitrazepam binding","volume":"268","author":"Wu","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2008.01.001_bib210","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF02736752","article-title":"Subunit- and brain region-specific reduction of GABAA receptor subunit mRNAs during chronic treatment of rats with diazepam","volume":"5","author":"Wu","year":"1994","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.pbb.2008.01.001_bib211","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/FBP.0b013e3282d28f2b","article-title":"Benzodiazepine-induced hippocampal CA1 neuron alpha-amino-3-hydroxy-5-methylisoxasole-4-propionic acid (AMPA) receptor plasticity linked to severity of withdrawal anxiety: differential role of voltage-gated calcium channels and N-methyl-d-aspartic acid receptors","volume":"18","author":"Xiang","year":"2007","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2008.01.001_bib212","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0028-3908(90)90052-S","article-title":"Local administration of flurazepam has different effects on dopamine release in striatum and nucleus accumbens: a microdialysis study","volume":"29","author":"Zetterstr\u00f6m","year":"1990","journal-title":"Neuropharmacology"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305708000051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305708000051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T13:46:35Z","timestamp":1737812795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305708000051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":214,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0091305708000051"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2008.01.001","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}